FRO Frontline Ltd

ZIM faces Q2 earnings with higher EPS estimates but steep year-over-year declines, rising costs, and trade tensions clouding its outlook.

ZIM slides 13.3% in six months amid tariff tensions, high debt, and dim earnings outlook. Should investors wait for now?

U.S. stocks were lower, with the Dow Jones index falling over 100 points on Monday. Shares of KalVista Pharmaceuticals, Inc. KALV rose sharply during Monday's session after the company announced it won FDA approval for EKTERLY. The U.S.

ZIM edges out FRO with a nimble business model, strong dividend payouts, and a superior valuation picture.

In the current market session, Frontline Inc. FRO share price is at $18.13, after a 0.17% drop. Over the past month, the stock went up by 5.96%, but over the past year, it actually decreased by 30.93%.

Frontline's FRO short percent of float has risen 10.78% since its last report. The company recently reported that it has 8.38 million shares sold short, which is 5.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.99 days to cover their ...